ANL Trademark

Trademark Overview


On Tuesday, November 5, 2024, a trademark application was filed for ANL with the United States Patent and Trademark Office. The USPTO has given the ANL trademark a serial number of 79416826. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 10, 2025. This trademark is owned by Hangzhou Adlai Nortye Biopharma Co., Ltd.. The ANL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations, namely, drugs for inhibiting tumors; medicines for humans for the treatment of tumor, immune, and metabolic-related diseases and disorders; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; pharmaceutical preparations in the form of tablets for the treatment of tumor, immune, and metabolic related diseases and disorders; nutritional supplements; dressings, medical; chemico-pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders
anl

General Information


Serial Number79416826
Word MarkANL
Filing DateTuesday, November 5, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, November 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations, namely, drugs for inhibiting tumors; medicines for humans for the treatment of tumor, immune, and metabolic-related diseases and disorders; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders; pharmaceutical preparations in the form of tablets for the treatment of tumor, immune, and metabolic related diseases and disorders; nutritional supplements; dressings, medical; chemico-pharmaceutical preparations for the treatment of tumor, immune, and metabolic related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 13, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHangzhou Adlai Nortye Biopharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Thursday, February 13, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 18, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 18, 2025APPLICATION FILING RECEIPT MAILED
Monday, March 31, 2025ASSIGNED TO EXAMINER
Monday, March 31, 2025NON-FINAL ACTION WRITTEN
Tuesday, April 1, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 4, 2025REFUSAL PROCESSED BY MPU
Wednesday, June 4, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 21, 2025REFUSAL PROCESSED BY IB
Wednesday, October 29, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 29, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 29, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 29, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 29, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, October 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 30, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 31, 2025APPROVED FOR PUB - PRINCIPAL REGISTER